Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102766098B details a novel synthesis route for 4-oxo quinolone compounds offering improved purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN106045883A reveals a novel metal-chelation route for Fmoc-Asp-OtBu, offering significant cost reduction and enhanced supply chain reliability for peptide synthesis.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN103923024B details water based recrystallization improving purity and yield reducing solvent toxicity for scalable acipimox manufacturing supply chains
Patent CN103242432A reveals a novel high-yield route for Phosphoramidon synthesis. Discover cost-effective manufacturing and scalable supply chain solutions for this critical biochemical reagent.
Advanced synthesis route for Lorcaserin intermediate offering cost reduction and scalability for pharmaceutical manufacturing supply chains globally.
Novel patent CN121318680A enables high-yield Bexagliflozin intermediate production with reduced costs and supply chain reliability for global buyers.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Novel regioselective protection strategy for >99% pure amino sugar phosphates, offering scalable manufacturing and simplified purification for pharmaceutical intermediates.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.
Patent CN108239128A reveals TMSOTf catalysis for high-purity beta-nucleosides. Enhances supply chain reliability and cost reduction in pharma manufacturing.
Patent CN115677587B enables high-purity antiviral intermediate production. Safe scalable process ensures reliable supply chain and significant cost efficiency.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.
Novel oxycodone synthesis uses ammonia treatment for copper removal. Enhances purity and scalability for pharmaceutical intermediate supply chains globally.
Patent CN115594600A reveals a safer, one-step synthesis of chiral (R)-3-aminobutanol using borohydride, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel diazotization method reduces costs for Afoxolaner intermediates. Mild conditions, high yield, scalable production for global supply chains.
Patent CN111205298A details a cost-effective Suzuki coupling route for Forbitasvir RRRS isomers, offering significant advantages in reaction time and purity for pharmaceutical manufacturing.
Patent CN111909067B reveals a novel 5-step total synthesis of D-penicillamine from L-serine, offering high optical purity and scalable production for pharmaceutical supply chains.
Patent CN102838533A reveals a novel 2-step synthesis for Roflumilast intermediates, offering improved yields and scalable routes for pharmaceutical manufacturing.
Novel bromine recycling method reduces cost and environmental risk for high-purity pharmaceutical intermediate manufacturing supply chain.